Prevalence of HIV drug resistance at antiretroviral treatment failure across regions of Russia

Documenti analoghi

• Real‐world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV‐1 sub‐subtype A6 harbouring the L74I mutation
  di: Elena Orlova‐Morozova, et al.
  Pubblicazione: (2025)
• Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment‐naïve individuals with HIV ‐1 in Türkiye
  di: Adem Özdemir, et al.
  Pubblicazione: (2025)
• Perspectives of people with HIV and HIV clinicians on characteristics of antiretroviral treatment and HIV‐related symptoms
  di: M. José Galindo Puerto, et al.
  Pubblicazione: (2024)
• Prevalence of people living with multidrug‐resistant HIV and limited treatment options in Spain
  di: Josep M. Llibre, et al.
  Pubblicazione: (2024)
• Lipid nanoparticles in antiretroviral therapy: A nanotechnology breakthrough for HIV/AIDS treatment
  di: D. Dulana C. Suriyarachchi, et al.
  Pubblicazione: (2025)